Matthew C. Kapusta - Mar 19, 2023 Form 3 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
Director
Signature
Jeffrey Schulz, Attorney-in-fact
Stock symbol
DBTX
Transactions as of
Mar 19, 2023
Transactions value $
$0
Form type
3
Date filed
3/21/2023, 04:10 PM
Previous filing
Mar 9, 2023
Next filing
Sep 25, 2023

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney